Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2810-2816

  Richards, Jeanette A ^a   Brueggemeier, Robert W ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 11 DEOXYPROSTAGLANDIN E1; 17 PHENYLTRINORPROSTAGLANDIN E2; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7ALPHA (4 AMINOPHENYLTHIO)ANDROSTENEDIONE; AROMATASE; MEMBRANE RECEPTOR; MESSENGER RNA; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID RECEPTOR; RECEPTOR SUBTYPE; TRITIUM OXIDE; UNCLASSIFIED DRUG; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; PROSTANOID RECEPTOR EP1;

ADIPOSE TISSUE; ARTICLE; ASSAY; BREAST; BREAST CANCER; CANCER GROWTH; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; WESTERN BLOTTING; CYTOLOGY; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

TRITIUM;

ADIPOSE TISSUE; AROMATASE; CELLS, CULTURED; DINOPROSTONE; HUMANS; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 0038239501     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021475     Document Type: Article

References (51)

1. Brodie A, Lu Q, Nakamura J 1997 Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol 61:281-286
2. Brodie A, Long B, Lu Q 1998 Aromatase expression in the human breast. Breast Cancer Res Treat 49:S85-S91
3. Sasano H, Murakami H 1998 Immunolocalization of aromatase in human breast disorders using different antibodies. Breast Cancer Res Treat 49:S79-S84
4. Shenton KC, Dowsett M, Lu Q, Brodie A, Sasano H, Sacks NP, Rowlands MG 1998 Comparison of biochemical aromatase activity with aromatase immunohistochemistry in human breast carcinomas. Breast Cancer Res Treat 49:S101-S107
5. Santen RJ, Santner SJ, Pauley RJ, Tait L, Kaseta J, Demers LM, Hamilton C, Yue W, Wang J-P 1997 Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible? J Steroid Biochem Mol Biol 61:267-271
6. Mahendroo MS, Mendelson CR, Simpson ER 1993 Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 268:19463-19470
7. Agarwal VR, Ashanullah CI, Simpson ER, Bulun SE 1997 Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J Clin Endocrinol Metab 82:70-74
8. Agarwal VR, Bulun SE, Simpson ER 1995 Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR. Mol Cell Probes 9:453-464
9. Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER 1996 Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab 81:3843-3849
10. Zhou D, Clarke P, Wang J, Chen S 1996 Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells. J Biol Chem 271:15194-15202
11. Bulun SE, Noble LS, Takayama K, Michael MD, Agarwal V, Fisher C, Zhao Y, Hinshelwood MM, Ito Y, Simpson ER 1997 Endocrine disorders associated with inappropriately high aromatase expression. J Steroid Biochem Mol Biol 61:133-139
12. Zhou D, Chen S 1999 Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene. Arch Biochem Biophys 371:179-190
13. Harada N 1997 Aberrant expression of aromatase in breast cancer tissues. J Steroid Biochem Mol Biol 61:175-184
14. Harada N, Honda S-I 1998 Molecular analysis of aberrant expression of aromatase in breast cancer tissues. Breast Cancer Res Treat 49:S15-S21
15. Zhou C, Zhou D, Esteban J, Murai J, Siiteri PK, Wilczynski S, Chen S 1996 Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol 59:163-171
16. Zhao Y, Agarwal VR, Mendelson CR, Simpson ER 1997 Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture. J Steroid Biochem Mol Biol 61:203-210
17. Zhou D, Zhou C, Chen S 1997 Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells. J Steroid Biochem Mol Biol 61:273-280
18. Pauley RJ, Santner SJ, Tait LR, Bright RK, Santen RJ 2000 Regulated CYP19 aromatase transcription in breast stromal fibroblasts. J Clin Endocrinol Metab 85:837-846
19. Reed MJ, Topping L, Coldham NG, Purohit A, Ghilchik MW, James VH 1993 Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. J Steroid Biochem Mol Biol 44:589-596
20. Purohit A, Ghilchik MW, Duncan L, Wang DY, Singh A, Walker MM, Reed MJ 1995 Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 80:3052-3058
21. 2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br J Cancer 72:1412-1419
22. 2 via cyclic AMP leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137:5739-5742
23. 1 subtype. J Biol Chem 268:26767-26772
24. 2 subtype. Mol Pharmacol 46:213-220
25. 3 subtype from human erythroleukaemia cells. Biochem J 298:263-267
26. 2. Biochem Biophys Res Commun 198:999-1006
27. 2. Biochem Biophys Res Commun 197:263-270
28. 2 subtype. J Biol Chem 269:11873-11877
29. Coleman RA, Smith WL, Narumiya S 1994 VIII. International union of pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229
30. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD 2001 Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661-690
31. 4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol Pharmacol 50:1031-1037
32. 4 and FP receptors in human ciliary epithelial and ciliary muscle cells. Biochem Pharmacol 53:1248-1255
33. 3 subtypes. Biochim Biophys Acta 1401:221-234
34. 2 receptors. Proc Natl Acad Sci USA 95:15792-15797
35. 4 in the nuclear envelope. J Biol Chem 274:15719-15724
36. Brueggemeier RW, Katlic NE 1987 Effects of the aromatase inhibitor 7α(4′-amino)-thiophenyl-4-androstene-3, 17-dione in human mammary carcinoma cell culture. Cancer Res 47:4548-4551
37. Brueggemeier RW, Li P-K, Snider CE, Darby MV, Katlic NE 1987 7α-substituted androstenediones as effective in vitro and in vivo inhibitors of aromatase. Steroids 50:163-170
38. Brueggemeier RW, Li P-K 1988 Effects of the aromatase inhibitor 7α(4′-amino)-thiophenyl-4-androstene-3, 17-dione on 7, 12-dimethyl-benz(a)anthracene-induced mammary carcinoma in rats. Cancer Res 48:6808-6810
39. Almadhidi J, Seralini G-E, Fresnel J, Silberzahn P, Galliard J-L 1995 Immunohisto-chemical localization of cytochrome P450 aromatase in equine gonads. J Histochem Cytochem 43:571-577
40. Quinn AL, Burak WE, Brueggemeier RW 1999 Effects of matrix components on aromatase activity in breast stromal cells in culture. J Steroid Biochem Mol Biol 70:249-256
41. Brueggemeier RW, Richards JA, Joomprabutra S, Bhat AS, Whetstone J 2001 Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents. Proceedings from the International Aromatase 2000 Symposium. J Steroid Biochem Mol Biol 79:75-84
42. Natarajan N, Shambaugh GE, Elseth KM, Haines GK, Radosevich JA 1994 Adaptation of the diphenylamine (DPA) assay to a 96-well plate tissue culture format and comparison with the MTT assay. Biotechniques 17:166-171
43. Richards JA, Petrel TA, Brueggemeier RW 2002 Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. Special Issue: proliferation of normal and malignant mammary epithelial cells. J Steroid Biochem Mol Biol 80:203-212
44. 2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br J Cancer 72:1412-1419
45. Karuppu D, Kalus A, Simpson ER, Clyne C 2002 Aromatase and prostaglandin inter-relationships in breast adipose tissue: significance for breast cancer development. Breast Cancer Res Treat 76:103-109
46. Hensby CH, MacDermot J 1979 Structure-activity relationships of prostanoids that activate adenylate cyclase of neuronal hybrid cells. Biochem Soc Trans 7:1302-1304
47. Miller WL, Weeks JR, Lauderdale JW, Kirton KT 1975 Biological activities of 17-phenyl-18, 19, 20-trinorprostaglandins. Prostaglandins 9:9-18
48. Dong YJ, Jones RL, Wilson NH 1986 Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br J Pharmacol 87:97-107
49. 2 receptor. Biochemistry 35:7159-7164
50. 2 receptor antagonist. Biochem Pharmacol 50:1731-1733
51. Schaaf TK, Bindra JS, Eggler JF, Plattner JJ, Nelson AJ, Johnson MR, Constantine JW, Hess H-J 1981 N-(methanesulfonyl)-16-phenoxyprostaglandin-carboxamides: tissue-selective, uterine stimulants. J Med Chem 24:1353-1359